TMX Newsfile News Releases (InvestorIdeas) [biotechnology]

Sharp Therapeutics Updates on '901 for Gaucher and GBA1 Parkinson's and Platform Programs

Fri, 10 Apr 2026 17:05:00 -0400

Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") announces that following longer-term non-GLP testing the company has decided to advance an alternative compound for its Gaucher and GBA1 Parkinson's programs. The company continues to advance all platform programs including programs for genetic and sporadic forms of neurodegeneration (Progranulin modulators), and a rare...

Sharp Therapeutics Announces Closing of Fourth Tranche of Unsecured Convertible Note Offering

Fri, 10 Apr 2026 17:00:00 -0400

Pittsburgh, Pennsylvania and Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Sharp Therapeutics Corp. (TSXV: SHRX) (OTCQB: SHRXF) ("Sharp" or the "Company") is pleased to announce that it has closed the fourth tranche (the "Fourth Tranche") of its previously announced non-brokered private placement for unsecured convertible notes of the Company (collectively, the "Notes"), in the principal amount of US$1,000 per Note (the "Note Offering"). Pursuant to completing the Fourth Tranche, the...

Younet AI Partners with Perpetuals.com to License and Co-Develop Forgentiq.ai Sovereign LLM and Agentic Technology Platform

Fri, 10 Apr 2026 10:21:00 -0400

Strategic Partnership Positions Both Companies at the Forefront of Institutional-Grade Digital Asset Market InfrastructureAnthropic-Broadcom Landmark Deal Securing 3.5 Gigawatts of TPU Capacity Validates the AI Infrastructure Thesis and Confirms Announced Today Vision of Enterprise-Grade Private AI as the Defining Asset Class of This DecadeToronto, Ontario--(Newsfile Corp. - April 10, 2026) - Younet AI, the enterprise-grade private AI solutions provider, today announced its strategic technology...

Theralase(R) Closes $CAN 2.66 Million Financing

Fri, 10 Apr 2026 07:00:00 -0400

Toronto, Ontario--(Newsfile Corp. - April 10, 2026) - Theralase® Technologies Inc. (TSXV: TLT) (OTCQB: TLTFF) ("Theralase®" or the "Company"), a clinical stage pharmaceutical company dedicated to the research and development of energy-activated small molecules for the safe and effective destruction of cancer, bacteria and viruses is pleased to announce that it has successfully closed both a non-brokered private placement offering ("Offering") of units ("Units") and a Line Of Credit ("LOC"). On...

iSpecimen Achieves 85% Reduction in Human Biospecimen Shipping Time

Thu, 09 Apr 2026 16:05:00 -0400

Woburn, Massachusetts--(Newsfile Corp. - April 9, 2026) - iSpecimen (NASDAQ: ISPC), an online marketplace for human biospecimens, has implemented a streamlined shipping model that enables direct shipment of biospecimens from supplier sites to customers, both domestically and internationally.By reducing reliance on centralized hub processing, the new model simplifies logistics and eliminates multi-step routing. Previously, shipments often required routing through a central hub, which could add...

Zenith Epigenetics Provides Update on ZEN-3694 NUT Carcinoma Program

Thu, 09 Apr 2026 16:00:00 -0400

Calgary, Alberta--(Newsfile Corp. - April 9, 2026) - Zenith Epigenetic Ltd. ("Zenith" or the "Company") today held its annual general meeting of shareholders ("AGM"), during which President & CEO Donald McCaffrey provided an update to investors on ZEN-3694's clinical development program for the treatment of NUT carcinoma. Highlights from the presentation are summarized below and a replay of the entire presentation may be found here.Expanded Access ProgramZenith has an active expanded access...

AtomVie Global Radiopharma to Present at The Bloom Burton & Co. Healthcare Investor Conference 2026

Thu, 09 Apr 2026 10:00:00 -0400

Hamilton, Ontario--(Newsfile Corp. - April 9, 2026) - AtomVie Global Radiopharma (AtomVie), a global leading radiopharmaceutical Contract Development and Manufacturing Organization (CDMO) specializing in GMP manufacturing for clinical and commercial supply of radiopharmaceuticals and their worldwide distribution, is pleased to announce that they will be presenting at the Bloom Burton & Co. Healthcare Investor Conference (BBHIC) 2026, taking place at the Metro Convention Centre in Toronto,...

Conavi Medical to Present at the 2026 Bloom Burton & Co. Healthcare Investor Conference

Thu, 09 Apr 2026 07:00:00 -0400

Toronto, Ontario--(Newsfile Corp. - April 9, 2026) - Conavi Medical Corp. (TSXV: CNVI) (OTCQB: CNVIF) ("Conavi" or the "Company"), a commercial stage medical device company focused on designing, manufacturing, and marketing imaging technologies to guide common minimally invasive cardiovascular procedures, today announced that Thomas Looby, CEO of Conavi Medical, will present and participate in one-on-one meetings at the 2026 Bloom Burton & Co. Healthcare Investor Conference to be held April 21...

Sernova Biotherapeutics Announces Affirmative Voting Results from 2026 Annual General Meeting of Shareholders

Thu, 09 Apr 2026 07:00:00 -0400

Toronto, Ontario and Boston, Massachusetts--(Newsfile Corp. - April 9, 2026) - Sernova Biotherapeutics Inc. (TSX: SVA) (OTC: SEOVF) (FSE: PSH0) ("Sernova" or the "Company"), a leading regenerative medicine company focused on developing its Cell Pouch Bio-hybrid Organ as a functional cure for type 1 diabetes (T1D), today announced the voting results from its Annual General Meeting of Shareholders (the "Meeting") held on April 8, 2026.At the Meeting, a total of 93,246,234 common shares were voted,...

Phio Pharmaceuticals Announces Presentation at Centri Capital Conference on April 14, 2026

Thu, 09 Apr 2026 07:00:00 -0400

King of Prussia, Pennsylvania--(Newsfile Corp. - April 9, 2026) - Phio Pharmaceuticals Corp. (NASDAQ: PHIO) is a clinical-stage siRNA biopharmaceutical company developing therapeutics using its proprietary INTASYL® gene silencing technology to eliminate cancer. Phio announced today that Robert Bitterman, Chief Executive Officer and Chairman of the Board, will present at the Centri Capital Conference on Tuesday, April 14, 2026, at Nasdaq Marketsite in New York City. The presentation will also be...